日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

调节 PPARγ 通路可上调 NECTIN4,并增强嵌合抗原受体 (CAR) T 细胞疗法在膀胱癌中的疗效

Chang Kevin, Delavan Henry M, Yip Elizabeth, Kasap Corynn, Zhu Jun, Lodha Roshan, Liao Sheng-You, Berman Sarah C, Carretero-Gonzalez Alberto, Basar Merve, Gokturk Ozcan Gamze, Teo Min Yuen, Solit David B, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Ding Cornelia C K, Chan Emily, Steri Veronica, Porten Sima P, Koshkin Vadim S, Friedlander Terence W, Feng Felix Y, Lee John K, Wiita Arun P, Chu Carissa E, Chou Jonathan

Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.

利用 PARP 抑制剂对 CDK12 缺陷型前列腺癌进行合成致死靶向治疗

Chou Jonathan, Robinson Troy M, Egusa Emily A, Lodha Roshan, Zhang Meng, Badura Michelle, Mikayelyan Mane, Delavan Henry M, Swinderman Jason, Wilson Chris, Zhu Jun, Das Rajdeep, Nguyen Minh, Loehr Andrea, Golsorkhi Tony, Simmons Andrew, Abida Wassim, Chinnaiyan Arul M, Arkin Michelle R, Small Eric J, Quigley David A, Yang Lixing, Kim Minkyu, Ashworth Alan, Feng Felix Y